KERX Keryx Biopharmaceuticals Inc.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Keryx Biopharmaceuticals, Inc. market cap is N/A.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Keryx Biopharmaceuticals, Inc. 52 week high is N/A as of May 06, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Keryx Biopharmaceuticals, Inc. 52 week low is N/A as of May 06, 2024.

Keryx Biopharmaceuticals, Inc. stock price today is $3.36.

Keryx Biopharmaceuticals, Inc. stock price yesterday was $3.43.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Keryx Biopharmaceuticals, Inc.’s P/E ratio is None.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Keryx Biopharmaceuticals, Inc. P/B ratio is None.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Keryx Biopharmaceuticals, Inc.'s EBITDA is -5.88.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Keryx Biopharmaceuticals, Inc. 50-day moving average is N/A.

Keryx Biopharmaceuticals, Inc. has N/A employees.